Herchenhorn, Daniel <br/><br/>
Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2011 
 - e283-4; author reply e285-7 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.33.8087  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>ErbB Receptors--antagonists & inhibitors<br/>Gefitinib<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Molecular Targeted Therapy<br/>Patient Selection<br/>Protein Kinase Inhibitors--administration & dosage<br/>Quinazolines--administration & dosage<br/>Radiation Tolerance<br/>Radiotherapy, Adjuvant<br/>Treatment Outcome